Abstract
Objective
To determine the differences in outcomes between mild and moderate isolated ventriculomegaly (IVM).
Methods
We conducted a prospective cohort study on 94 fetuses with IVM and evaluated the neurodevelopmental outcomes at 12 months of age using the ASQ-3 and BSID-I neurodevelopmental assessment tools. Progression of VM was defined as an increase in the width of the ventricular by at least 3 mm during sequential ultrasound monitoring. The population was divided into two groups according to ventricular width: mild (10–12 mm) and moderate (12.1–15 mm), which were further evaluated for VM progression in utero separately.
Results
Neurodevelopmental assessments at 12 months were the main form of evaluations. Neurodevelopmental impairment (NDI) was defined as a mental development index (MDI) or psychomotor development index (PDI) < 85. There were no significant differences in NDI values between the mild and moderate groups (p = .155). Compared with the non-in utero progression group (7.6%), the rate of NDI was significantly higher (p = .004) in the group with progression (33.3%). Using linear regression and correlation, no negative correlation was found between the maximum value of atrial diameter (AD) in utero and the PDI (r = –0.021, p = .914) or MDI (r = –0.073, p = .703) score. However, the maximum change in the AD in utero was negatively correlated with both PDI (r = –0.460, p = .011) and MDI (r=–0.422, p = .020) scores.
Conclusion
There were likely no differences in neurodevelopmental outcomes between mild and moderate IVM. In fetuses with mild to moderate VM, intrauterine progression may be a poor prognostic factor for neurodevelopmental outcomes.
Disclosure statement
There is no competing financial interests in relation to the work described. The authors declare that they have no conflicts of interest.
Author contributions
Guoyu Sun and Baihua Jing are responsible for analyzing the data and writing the manuscript. Junya Chen and Xinlin Hou conceived this study and were in charge of the follow-up from antenatal to postnatal. Lili Liu, Hongyan Liu and Faliang Zhou are responsible for collecting and analyzing the data, as well as being coordinators for parents and doctors.